Phase II Trial Shows Favorable Response for Patients Receiving Combination Therapy With SurVaxM This is very impressive. 93% of GBM patients alive at 1 year compared to 65% historical controls. This treatment is a simple vaccine injection that does not require brain tumor tissue. It is just a shot in the arm or leg similiar to a flu vaccine, and has minimal to no side effects. A clinical trial recently opened at the Cleveland Clinic, which will combine a checkpoint inhibitor with the vaccine.
Attend an Optune Open House. These meeting are to learn about Optune and meet people who are using it! One of them can be done online, the rest are real wolrd. Very much worth attending if you have a GBM or know someone who has one!
Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board The virtual trial they are talking about is the next generation of our virtual trial registry. It takes the giant leap into offering ideas for treatment options. Our program never suggested anything - just observed what patients did and the outcome. This new program will evaluate each patient and come up with ideas for treatment options that fit their specific profile.
Disclaimer: I own stock in this company and am a consultant for it.
